Blood Loss clinical trials

Explore recruiting blood loss clinical trials.

Recruiting blood loss studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Blood Loss trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pooled human plasma vs. Crystalloid in the fluid management of children undergoing instrumented spinal fusion for scoliosis. A double-blind, randomized clinical trial.

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Influence of Argipressin on blood loss during liver resection; a double-blinded, randomized, placebo-controlled trial (ARG-01)

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Reduction of blood loss in pediatric osteotomies around the hip - A randomized placebo-controlled trial with tranexamic acid

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Evaluation of intra articular Tranexamic acid for reduction of total blood loss in total hip arthroplasty

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy and safety of octreotide in laparoscopic hepatectomy surgery: effect on blood loss, need for vasoactive drugs, transfusion requirement.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

“Randomized, double-blind clinical trial to assess the efficacy of tranexamic acid in reducing blood loss in patients with hip fracture”.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Blood Loss trials by city

Blood Loss in Toronto Blood Loss in Vancouver Blood Loss in Montreal Blood Loss in Calgary Blood Loss in Edmonton Blood Loss in Ottawa Blood Loss in Winnipeg Blood Loss in Quebec City Blood Loss in Hamilton Blood Loss in Kitchener Blood Loss in London Blood Loss in Halifax Blood Loss in New York Blood Loss in Los Angeles Blood Loss in Chicago Blood Loss in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease